Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Perilongo

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Arthritis and Rheumatism|February 10, 2011
Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trialFrancesco Zulian, Giorgia Martini, Cristina Vallongo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 28, 2012
Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL)József Zsíros, Laurence Brugières, Penelope Brock, et al.
Journal of Child Neurology|April 13, 2011
Pathogenic role of the X-linked cyclin-dependent kinase-like 5 and aristaless-related homeobox genes in epileptic encephalopathy of unknown etiology with onset in the first year of lifeStefano Sartori, Roberta Polli, Elisa Bettella, et al.
Pediatric Blood & Cancer|September 19, 2017
Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL groupPatrizia Dall'Igna, Laurence Brugieres, Anne Sanlaville Christin, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) reportDaniel C Aronson, Víola B Weeda, Rudolf Maibach, et al.
Pediatric Radiology|December 23, 2006
2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL groupDerek J Roebuck, Daniel Aronson, Philippe Clapuyt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2012
Prognostic stratification for children with hepatoblastoma: the SIOPEL experienceRudolf Maibach, Derek Roebuck, Laurence Brugieres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR studyJózsef Zsíros, Rudolf Maibach, Elizabeth Shafford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 StudiesMaciej Murawski, Víola B Weeda, Rudolf Maibach, et al.
The New England Journal of Medicine|October 23, 2009
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastomaGiorgio Perilongo, Rudolf Maibach, Elisabeth Shafford, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Arthritis and Rheumatism|February 10, 2011
Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trialFrancesco Zulian, Giorgia Martini, Cristina Vallongo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 28, 2012
Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL)József Zsíros, Laurence Brugières, Penelope Brock, et al.
Journal of Child Neurology|April 13, 2011
Pathogenic role of the X-linked cyclin-dependent kinase-like 5 and aristaless-related homeobox genes in epileptic encephalopathy of unknown etiology with onset in the first year of lifeStefano Sartori, Roberta Polli, Elisa Bettella, et al.
Pediatric Blood & Cancer|September 19, 2017
Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL groupPatrizia Dall'Igna, Laurence Brugieres, Anne Sanlaville Christin, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) reportDaniel C Aronson, Víola B Weeda, Rudolf Maibach, et al.
Pediatric Radiology|December 23, 2006
2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL groupDerek J Roebuck, Daniel Aronson, Philippe Clapuyt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2012
Prognostic stratification for children with hepatoblastoma: the SIOPEL experienceRudolf Maibach, Derek Roebuck, Laurence Brugieres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR studyJózsef Zsíros, Rudolf Maibach, Elizabeth Shafford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 StudiesMaciej Murawski, Víola B Weeda, Rudolf Maibach, et al.
The New England Journal of Medicine|October 23, 2009
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastomaGiorgio Perilongo, Rudolf Maibach, Elisabeth Shafford, et al.
Pageof 13